GUTS
Price
$1.33
Change
+$0.33 (+32.67%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
71.53M
53 days until earnings call
MNKD
Price
$5.54
Change
+$0.21 (+3.94%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
1.64B
46 days until earnings call
Interact to see
Advertisement

GUTS vs MNKD

Header iconGUTS vs MNKD Comparison
Open Charts GUTS vs MNKDBanner chart's image
Fractyl Health
Price$1.33
Change+$0.33 (+32.67%)
Volume$218.07K
Capitalization71.53M
MannKind
Price$5.54
Change+$0.21 (+3.94%)
Volume$483.77K
Capitalization1.64B
GUTS vs MNKD Comparison Chart in %
Loading...
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GUTS vs. MNKD commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GUTS is a Buy and MNKD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (GUTS: $1.34 vs. MNKD: $5.54)
Brand notoriety: GUTS and MNKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GUTS: 1560% vs. MNKD: 89%
Market capitalization -- GUTS: $71.53M vs. MNKD: $1.64B
GUTS [@Biotechnology] is valued at $71.53M. MNKD’s [@Biotechnology] market capitalization is $1.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GUTS’s FA Score shows that 0 FA rating(s) are green whileMNKD’s FA Score has 0 green FA rating(s).

  • GUTS’s FA Score: 0 green, 5 red.
  • MNKD’s FA Score: 0 green, 5 red.
According to our system of comparison, MNKD is a better buy in the long-term than GUTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GUTS’s TA Score shows that 4 TA indicator(s) are bullish while MNKD’s TA Score has 4 bullish TA indicator(s).

  • GUTS’s TA Score: 4 bullish, 3 bearish.
  • MNKD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, GUTS is a better buy in the short-term than MNKD.

Price Growth

GUTS (@Biotechnology) experienced а +35.05% price change this week, while MNKD (@Biotechnology) price change was +2.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

GUTS is expected to report earnings on Nov 18, 2025.

MNKD is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNKD($1.64B) has a higher market cap than GUTS($71.5M). MNKD YTD gains are higher at: -13.841 vs. GUTS (-50.971). MNKD has higher annual earnings (EBITDA): 79.1M vs. GUTS (-98.85M). MNKD has more cash in the bank: 179M vs. GUTS (22.3M). MNKD has less debt than GUTS: MNKD (46.8M) vs GUTS (61.7M). MNKD has higher revenues than GUTS: MNKD (302M) vs GUTS (17K).
GUTSMNKDGUTS / MNKD
Capitalization71.5M1.64B4%
EBITDA-98.85M79.1M-125%
Gain YTD-50.971-13.841368%
P/E RatioN/A48.45-
Revenue17K302M0%
Total Cash22.3M179M12%
Total Debt61.7M46.8M132%
FUNDAMENTALS RATINGS
MNKD: Fundamental Ratings
MNKD
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
48
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GUTSMNKD
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 23 days ago
90%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HMNTY26.100.46
+1.79%
HEMNET GROUP AB
RWCI14.25N/A
N/A
RWC, Inc.
HVLM28.50N/A
N/A
Huron Valley Bancorp, Inc.
WPNTF6.20N/A
N/A
Warpaint London PLC
TIAIY5.52-0.12
-2.21%
Telecom Italia S.p.A.

GUTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GUTS has been loosely correlated with VRTX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GUTS jumps, then VRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GUTS
1D Price
Change %
GUTS100%
+2.28%
VRTX - GUTS
35%
Loosely correlated
+1.39%
RCKT - GUTS
32%
Poorly correlated
-3.92%
NEVPF - GUTS
31%
Poorly correlated
N/A
MNKD - GUTS
31%
Poorly correlated
N/A
TAOX - GUTS
31%
Poorly correlated
-8.22%
More

MNKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with IONS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
+3.94%
IONS - MNKD
48%
Loosely correlated
+1.78%
CYTK - MNKD
45%
Loosely correlated
+5.37%
UTHR - MNKD
39%
Loosely correlated
+1.69%
DAWN - MNKD
38%
Loosely correlated
+1.35%
MLYS - MNKD
38%
Loosely correlated
+3.82%
More